Grace Therapeutics (GRCE)
NASDAQ:GRCE
Holding GRCE?
Track your performance easily

Grace Therapeutics (GRCE) Cash flow

1,140 Followers

Grace Therapeutics Cash Flow

GRCE's free cash flow for Q1 2025 was $-3.60M. For the 2025 fiscal year, GRCE's free cash flow was decreased by $3.69M and operating cash flow was $-3.60M. See a summary of the company’s cash flow.
Cash Flow
TTM
Mar 24Mar 23Mar 22Mar 21Mar 20
Operating Cash Flow
$ -9.69M$ -12.33M$ -15.91M$ -17.23M$ -14.32M$ -22.95M
Investing Cash Flow
$ 89.00K$ 104.00K$ 13.15M$ -3.52M$ -9.86M$ 8.14M
Financing Cash Flow
$ 7.36M$ 7.36M$ 304.00K-$ 59.49M$ 13.18M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 87.94M$ 23.00M$ 27.88M$ 30.34M$ 50.94M$ -17.30M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
$ 7.34M$ 7.34M$ 304.00K-$ 59.33M$ 6.98M
Issuance Of Debt
-----$ -1.56M
Repayment Of Debt
-----$ -1.56M
Free Cash Flow
$ -9.60M$ -12.24M$ -15.93M$ -17.23M$ -14.39M$ -23.27M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Grace Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis